teaser
Drug companies and healthcare public relations consultancies have been urged to pay closer attention to reputation management by focusing on sustainability and stakeholder management.
The call was made to delegates at the Pharmaceutical Responsibility and Reputation Conference, held at the multi-campus Thames Valley University (TVU), which saw 11 industry heads sharing best practice.
Speakers included senior staff from Johnson and Johnson, Procter and Gamble, Janssen-Cilag, Pfizer, Novartis, Roche, GlaxoSmithKline, AstraZeneca, Wyeth and the Association of the British Pharmaceutical Industry.
The meeting was also attended by healthcare PR professionals and PR students. The event forms part of TVU’s MSc in Corporate Communication, with the students assessing the analysis of reputation within the industry to contribute to the debate about where responsibility and reputation is failing and not failing.
Your comments: (Terms and conditions apply)
“I’d like to direct your readers’ attention to the conference website, at www.tvu.ac.uk/pharma.”– Kunal Mehta, Pharmaceutical Responsibility and Reputation Conference director/MSc corporate communication course lecturer, Thames Valley University, UK
